Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02238496
Title Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Andrew Lassman
Age Groups: adult
Covered Countries USA

No variant requirements are available.